Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.96 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.65 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.65 | 17418594 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.38 | 15688382 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.89 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.89 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.50 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.50 | 16162502 16183991 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.56 | 17115116 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
3.42 | 16516891 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.33 | 17967414 16873680 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
5.20 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.78 | 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.87 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.61 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.44 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.91 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.07 | 19526202 17426702 15668708 15692762 16096432 16264153 18628466 16826403 18234424 15993339 15136595 16115903 16322301 17369602 18382427 18695136 11325840 15634643 15939500 16935488 15994142 17983394 15567936 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.07 | 15758505 17049068 17261762 16912660 15572757 15775269 17952589 17595753 17893378 17440819 16837676 17242785 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.07 | 17534123 16393696 17651959 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.45 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.07 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.98 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.75 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
6.75 | 15553829 16217749 14691202 11135700 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.75 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.75 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.75 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.05 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.20 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.22 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
7.94 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.94 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.94 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.17 | 17572228 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.60 | 15476868 17351982 16612575 15792986 17329180 17928571 17131338 17974986 17308081 15811867 16455267 16952015 16109756 16651473 15505089 17382496 17924179 16278810 16269455 18627295 16364871 16242529 16731534 17007740 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.81 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.81 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.76 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.76 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
11.76 | 18226522 |
MESH:D002761 |
Cholangitis |
|
1-Naphthylisothiocyanate |
6.38 | 12912871 |
MESH:D002779 |
Cholestasis |
|
1-Naphthylisothiocyanate |
4.41 | 16629650 15500046 7624871 18590720 15913567 12927374 19486331 18164287 |
MESH:D002780 |
Cholestasis, Intrahepatic |
|
1-Naphthylisothiocyanate |
6.03 | 10220858 19407337 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.76 | 15800139 |
MESH:D003092 |
Colitis |
|
resveratrol |
10.12 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
10.12 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.47 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.56 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.56 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.56 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.82 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.31 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.74 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.74 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.48 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.21 | 15213294 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.26 | 17474826 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.86 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
3.30 | 16988119 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.54 | 17308373 15920148 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.54 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-Naphthylisothiocyanate |
12.40 | 20133375 7624871 17522070 18289764 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.40 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
12.40 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.40 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
12.40 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.75 | 18602426 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.88 | 9068938 |
MESH:D004487 |
Edema |
|
Raloxifene |
7.58 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
7.58 | 8985016 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.85 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.85 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.52 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.33 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.99 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.54 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.54 | 12903497 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.40 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.40 | 17473493 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.74 | 19069698 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.39 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.42 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.60 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.04 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
8.09 | 16495754 16244371 16244372 16144979 14766674 16879835 16707910 18006777 16330681 17888722 18674790 12587719 17875725 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
8.09 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.46 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.46 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.01 | 15692506 |
MESH:D006505 |
Hepatitis |
|
1-Naphthylisothiocyanate |
4.82 | 18590720 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.73 | 16490937 16863852 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.33 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.50 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.15 | 14716179 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.11 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.14 | 16873680 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.90 | 15787275 17577099 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.41 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.78 | 17600658 |
MESH:D007249 |
Inflammation |
|
resveratrol |
2.89 | 16366677 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
19.69 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
19.69 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
19.69 | 16624496 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.48 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.48 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.35 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.35 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.07 | 16705839 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.61 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.88 | 15070760 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.33 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.90 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.46 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.51 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.87 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.15 | 17050201 16968895 20471514 19850784 16467208 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
8.02 | 16966277 12018890 17649720 15213294 16823087 16331271 15622746 19035177 11161223 19642359 17869043 12712474 19225113 17217047 12679006 16330433 17712046 16112521 19075265 11468182 16891316 9834237 15336539 17107899 15748426 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
8.02 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.48 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.80 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
3.80 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.80 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
1-Naphthylisothiocyanate |
3.21 | 17184895 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.75 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.75 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.75 | 20405173 19812893 19321006 19073162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.31 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
10.31 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.31 | 17085340 16842330 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.43 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
8.01 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
8.01 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.59 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.59 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
3.59 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.54 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.42 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.19 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
9.19 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.70 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.40 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
10.49 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
10.49 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
10.49 | 15318939 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.44 | 16827129 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
5.44 | 17992120 11746506 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.44 | 17992120 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.42 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.42 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.49 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.61 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.73 | 15863610 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.94 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
12.65 | 14977855 15949261 19417148 11468182 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
12.65 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
12.65 | 14749477 16267019 17935668 17049120 17164350 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
13.15 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
13.15 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.85 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.20 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.17 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
6.17 | 17015251 16525036 16317513 17188708 17125593 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
4.09 | 17125593 17015251 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.91 | 17322642 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.73 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.09 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
6.39 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.39 | 18259882 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.14 | 8985016 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.91 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.10 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
7.89 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.89 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.31 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.90 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.52 | 17929310 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.53 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.46 | 19059307 15775268 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
10.60 | 17893378 15758505 17823083 15579764 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
10.60 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.20 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.44 | 16624393 19769630 12452020 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.56 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.28 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
1-Naphthylisothiocyanate |
6.03 | 20133375 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.33 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.06 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.33 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
4.33 | 16679765 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.88 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.88 | 18437689 16868541 15897917 16888761 16729912 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.88 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.88 | 17718901 17804756 17675339 17636462 15767336 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.88 | 15084515 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.73 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.36 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.76 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.32 | 16317513 17058453 16314181 17520802 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.64 | 12210543 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.09 | 16767912 17203757 15675481 17710206 18313854 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
10.71 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.71 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.94 | 17846226 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.46 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.21 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
6.21 | 15837718 8985016 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.70 | 17203757 16767912 15625365 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
4.10 | 17918041 |
MESH:D020521 |
Stroke |
|
Raloxifene |
9.01 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
9.01 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.58 | 16321402 |
MESH:D013921 |
Thrombocytopenia |
|
1-Naphthylisothiocyanate |
4.86 | 20133375 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.62 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.62 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.38 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.31 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.11 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.30 | 12973940 20435036 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
12.30 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
12.30 | 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.20 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.26 | 17044934 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.38 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
10.81 | 17638931 16364871 17678736 17334414 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
10.81 | 17488730 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.73 | 16343187 |